tiprankstipranks
Trending News
More News >
MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
US Market
Advertisement

MoonLake Immunotherapeutics (MLTX) Financial Statements

Compare
395 Followers

MoonLake Immunotherapeutics Financial Overview

MoonLake Immunotherapeutics's market cap is currently $3.46B. The company's EPS TTM is $-0.87; its P/E ratio is ―; MoonLake Immunotherapeutics is scheduled to report earnings on August 5, 2025, and the estimated EPS forecast is $-0.87. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

MoonLake Immunotherapeutics Earnings and Revenue History

MoonLake Immunotherapeutics Debt to Assets

MoonLake Immunotherapeutics Cash Flow

MoonLake Immunotherapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis